Skip to main content
Log in

Adverse events during placebo vs. no drug administration—results of a randomised interventional trial in 160 volunteers

  • Letter to the Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Garattini S, Bertelé V, Banzi R (2013) Placebo? No thanks, it might be bad for me! (2012). Eur J Clin Pharmacol 69(3):711–714

    Article  PubMed  Google Scholar 

  2. Häuser W, Hansen E, Enck P (2012) Nocebo phenomena in medicine: their relevance in everyday clinical practice. Dtsch Arztebl Int 109:459–465

    PubMed Central  PubMed  Google Scholar 

  3. Symon A, Williams B, Adelasoye QA, Cheyne H (2015) Nocebo and the potential harm of ‘high risk’ labelling: a scoping review. J Adv Nurs. doi:10.1111/jan.12637

    PubMed  Google Scholar 

  4. Erbguth F (1984) Placebo-Nebenwirkungen bei jungen und alten nicht hospitalisierten Personen. MD Thesis. Medical Faculty, Friedrich-Alexander-Universität, Erlangen-Nürnberg, Germany

  5. Hamacher A (1984) Placebo-Nebenwirkungen bei jungen und alten hospitalisierten Personen. MD Thesis. Medical Faculty, Friedrich-Alexander-Universität, Erlangen-Nürnberg, Germany

  6. Guy W, Cleary PA (1976) Pretreatment status and its relationship to the length of drying-out period. Psychopharmacol Bull 12(2):20–22

    CAS  PubMed  Google Scholar 

  7. Blaha L, Glaster JV (1976) Die quantitative Erfassung der Tranquilizerwirkung auf Angstsyndrome. Psychopathometrie 2:74–81

    Google Scholar 

  8. Colloca L, Miller FG (2011) The nocebo effect and its relevance for clinical practice. Psychosom Med 73(7):598–603

    Article  PubMed Central  PubMed  Google Scholar 

  9. Wells RE, Kaptchuk TJ (2012) To tell the truth, the whole truth, may do patients harm: the problem of the nocebo effect for informed consent. Am J Bioeth 12(3):22–29

    Article  PubMed Central  PubMed  Google Scholar 

  10. Amanzio M (2011) Do we need a new procedure for the assessment of adverse events in anti-migraine clinical trials? Recent Pat CNS Drug Discov 6(1):41–47

    Article  CAS  PubMed  Google Scholar 

  11. Heisig SR, Shedden-Mora MC, Hidalgo P, Nestoriuc Y. Framing and personalizing informed consent to prevent negative expectations: an experimental pilot study. Health Psychol. 2015

Download references

Conflict of interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fritz Sörgel.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Erbguth, F., Hamacher-Erbguth, A., Fuhr, U. et al. Adverse events during placebo vs. no drug administration—results of a randomised interventional trial in 160 volunteers. Eur J Clin Pharmacol 71, 1403–1405 (2015). https://doi.org/10.1007/s00228-015-1900-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-015-1900-5

Keywords

Navigation